FDA Issues New Draft Guidelines On Genome Editing And CAR-T

CAR-T (chimeric antigen receptor T-cell) therapy is a relatively new blood cancer treatment that has, in some cases, cured patients where other treatments have failed.

Related Keywords

James Drake , Science Group , Drug Administration , Human Gene Cell Therapy , Genome Editing , Regenerative Medicine , Future Science Group ,